CORT vs PAYX · P/E 199, rev $421.1M vs P/E 22, rev $6.51B
Corcept Therapeutics Incorporated (CORT) versus Paychex Inc (PAYX) — a side-by-side from cached financials, not a winner call.
Corcept Therapeutics Incorporated (CORT) is a biotechnology company listed on US.
Paychex Inc (PAYX) is a software - application company listed on NASDAQ.
Latest reported CORT revenue for 2026-06-30 was $421.1M. Net income was $11.2M. CORT currently screens at market cap $7.46B and trailing P/E 198.5.
Latest reported PAYX revenue for 2026-05-31 was $6.51B. Net income was $1.76B. Revenue was up 16.9% from 2025-05-31 to 2026-05-31. PAYX currently screens at market cap $34.96B and trailing P/E 21.5.
CORT currently screens at market cap $7.46B and trailing P/E 198.5. PAYX currently screens at market cap $34.96B and trailing P/E 21.5.
Not investment advice. Open the CORT and PAYX stock pages for the full models.
Not investment advice.